Inhibitors of Efflux Pumps in Pseudomonas aeruginosa Potentiate the Activity of the Fluoroquinolone Antibacterial Levofloxacin-Reference-Cited by-同舟云学术

Inhibitors of Efflux Pumps in Pseudomonas aeruginosa Potentiate the Activity of the Fluoroquinolone Antibacterial Levofloxacin

Published:1999-11-10 Issue:24 Volume:42 Page:4928-4931
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Renau Thomas E.¹,Léger Roger¹,Flamme Eric M.¹,Sangalang Joan¹,She Miles W.¹,Yen Rose¹,Gannon Carla L.¹,Griffith David¹,Chamberland Suzanne¹,Lomovskaya Olga¹,Hecker Scott J.¹,Lee Ving J.¹,Ohta Toshiharu¹,Nakayama Kiyoshi¹

Affiliation:

1. Microcide Pharmaceuticals Inc., 850 Maude Avenue, Mountain View, California 94043, and New Product Research Laboratories I, Daiichi Pharmaceutical Company Ltd., 1-16-13, Kita-Kasai, Edogawa, Tokyo 134-8630, Japan

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm9904598

Reference38 articles.

1. Role and regulation of cyclooxygenase-2 during inflammation

2. Research and development of antibacterial agents

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds;Microbiology Spectrum;2024-01-03

2. Bibliometric insights into the most influential papers on antibiotic adjuvants: a comprehensive analysis;Frontiers in Pharmacology;2023-11-13

3. Identification of efflux pump inhibitors for Pseudomonas aeruginosa MexAB-OprM via ligand-based pharmacophores, 2D-QSAR, molecular docking, and molecular dynamics approaches;Molecular Diversity;2023-11-03

4. Synthesis of peptidomimetics as antibiotic adjuvants for combination with aztreonam to combat MDR Pseudomonas aeruginosa;European Journal of Medicinal Chemistry;2023-11

5. Advances in the Discovery of Efflux Pump Inhibitors as Novel Potentiators to Control Antimicrobial-Resistant Pathogens;Antibiotics;2023-09-07